Structured Summary
Abstract
A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- Glu-Plasmin
- Plasmin
- Protease F
- Glu Plasmin
- Fibrogammin
- Thrombolysin
MeSH Record
Aspects Covered
28 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, antagonists & inhibitors, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2010, 1963-1992;
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Fibrinolysin. Medical Subject Headings (MeSH). 2026. Unique ID D005341. http://id.nlm.nih.gov/mesh/2026/D005341
- Fibrinolysin. In: Wikipedia. https://en.wikipedia.org/wiki/Fibrinolysin
- Fibrinolysin. In: Wikidata. https://www.wikidata.org/wiki/Q2619971